Thermo Fisher Scientific Pembrolizumab Polyclonal Antibody

Applications

ELISA (ELISA)

• Tested Dilution: 0.01–0.1 µg/mL

Product Specifications

Product Specific Information

• Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
• Pembrolizumab (Keytruda) is a humanized monoclonal antibody approved by the U.S. FDA for treatment of unresectable or metastatic melanoma.
• Pembrolizumab binds to the human PD-1 (Programmed Cell Death Protein 1) receptor and blocks its interaction with PD-L1, leading to activation of T-cell-mediated immune responses against tumor cells.
• This rabbit polyclonal antibody is produced from sera of a rabbit immunized with Pembrolizumab.

Target Information

Pembrolizumab (Keytruda) is a humanized monoclonal antibody approved by the U.S. FDA for the treatment of patients with unresectable or metastatic melanoma. It binds PD-1 and blocks PD-L1 interaction, enhancing T-cell-mediated immune responses against tumors.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.